SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Pentixapharm Expects First PANDA Phase 3 Patient in Q1 2027

Valid market news retained in the public archive without immediate LiveCast distribution.

Related stories